GetTopicDetailResponse(id=6f091e510cc, topicName=TKI耐藥, introduction=TKI耐藥, content=null, image=null, comments=0, allHits=824, url=https://h5.medsci.cn/topic?id=17510, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=86018, tagList=[TagDto(tagId=86018, tagName=TKI耐藥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2255212, encodeId=0c1222552128a, content=<a href='/topic/show?id=211e823029d' target=_blank style='color:#2F92EE;'>#肺腺癌#</a> <a href='/topic/show?id=6f091e510cc' target=_blank style='color:#2F92EE;'>#TKI耐藥#</a>, objectTitle=發(fā)生小細胞轉(zhuǎn)化的TKI耐藥EGFR突變肺腺癌具有怎樣的分子特征？, objectType=article, longId=866254, objectId=625686625443, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867304452_4754896.png, objectUrl=/article/show_article.do?id=625686625443, replyNumber=0, likeNumber=57, createdTime=2025-03-08, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=625686625443, moduleTitle=發(fā)生小細胞轉(zhuǎn)化的TKI耐藥EGFR突變肺腺癌具有怎樣的分子特征？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=625686625443)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
